Newsletter Subject

American Greed: They “Stole” From Baby Yoda’s Company!!

From

biotechbreakouts.com

Email Address

kyle@biotechbreakouts.com

Sent On

Tue, Dec 24, 2019 06:52 PM

Email Preheader Text

Hello trader, I hope you got off early for the holidays, and are enjoying some much-needed relaxatio

Hello trader, I hope you got off early for the holidays, and are enjoying some much-needed relaxation and time with friends and family. In the spirit of the holidays and the latest Star Wars moving dropping… I wanted to bring to your attention an [insider trading]( case that Yoda will not approve of. [Image]( Walt Disney Co (DIS) is one of the hottest companies on the market… and it seems like they’re always acquiring companies left and right. It’s their way of showing their dominance and why they’re able to put out such amazing content for the world. For a company so massive, there will be some bad apples in there… those who don’t play by the rules and dole out non-public information. I hate spoilers. [These “insiders” don’t care if it’s illegal](, and I don’t think they should work at a place that puts as much joy into people’s lives like Disney. How One Well-Informed Trader Turned $5,400 into $192,000! Back in 2011, there was a high-profile case that involved Marvel Entertainment (acquired by DIS) and Walt Disney Co. An investment manager — Toby Scammell (who was just 26 at the time) — had a girlfriend who worked at Marvel. Scammell purchased some pretty deep out-of-the-money call options in Marvel in mid-August 2009. Heck, this guy didn’t really try to hide his purchases. He dropped bought $45 and $50 strike price calls… and Marvel had never traded above $41.74 then. Not only that, but the options he purchased were set to expire on Sept. 19, 2009… just weeks after the announcement. [Those trades were so unusual]( at the time that he was the entire open interest in some of those contracts. He was essentially the market in them. Here’s the kicker, he used his brother’s account to buy those options. Before he bought them, he apparently searched for the terms “insider trading” and “material non-public information”. He knew something was up… and he even knew [what insider trading is](. Yet, he decided to place the bet ahead of this catalyst. [Image] Of course, he didn’t even tell his girlfriend or brother he turned $5,400 into nearly $200,000… a whopping 3,000% return in less than a month. According to Rosalind R. Tyson, director of the SEC’s LA regional office at the time, “Scammell exploited his romantic relationship for a financial windfall...His misuse of confidential information gave him an unfair and illegal edge over other traders in the markets.” Scammell’s girlfriend wasn’t charged with anything because she didn’t mention the company name… but he may have overheard a conversation or even looked at her emails and work, who knows. Piggybacking off baby Yoda’s company and trading off [inside information]( is no way to play this game. The worst part about this is the fact there are still [well-informed traders out there who place unusual options activity trades…]( just as Scammell did. However, what you may not know is the fact that [you can directly profit from their move](. Best of all, it’s 100% legal. Becoming A Jedi Trader [Dollar Ace is the one single strategy that helped me uncover massive profits]( in the options during the second half of 2019. I came up with a strategy that allows me to detect some pretty wild options bets. [Image]( I realized [how Wall Street’s elite and billionaires really operate](. They have access to inside information, and covertly place bets in the options market. All you have to do is find these trades and come up with a thesis. It’s really that simple. I don’t know any of the information at all… everything [my Dollar Ace strategy]( utilizes is there for the public to see. For example, check out this near-triple digit winner in Lumber Liquidators (LL). I spotted an unusual options activity trade in LL. It wasn’t as crazy as Scammell’s bet, but it was sizable. A whale came in and bought 2,409 calls in LL for 30 cents a piece, and those options had just about 2 weeks until expiration. It was a clear signal someone knew something. So what did I do? I came up with a thesis, and followed suit. [Image]( Guess what happened not too long after? The company updated its 2019 financial outlook and raised guidance! That’s a massive catalyst that caused the stock to rocket higher. [Image] [Image] Sure, the stock moved a lot (more than 15% in a single day), but those options were up nearly 100%... and of course, I took my profits off the table. [Image]( If you take just a little bit of time during your holiday and attend my special training session... [you will learn how you can effortlessly generate fresh trade ideas and uncover massive profits in the options market.]( Cheers to Profits! [Image] Kyle Dennis [Special]( RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from kyle@biotechbreakouts.com]( [Unsubscribe from all RagingBull emails]( Neither Kyle Dennis nor RagingBull.com, LLC (publisher of BiotechBreakouts) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. The owners, employees and writers of RagingBull.com may engage in securities trading that is discussed or viewed on this website, but all such individuals are buying and selling such securities for their own account. These individuals do not engage in any trades with customers. The buying and selling of securities by these individuals is not part of a regular business of buying and selling securities. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter, but all such positions are held for such representative’s own account. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Kyle Dennis manages on behalf of RagingBull.com, LLC. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.

Marketing emails from biotechbreakouts.com

View More
Sent On

31/07/2021

Sent On

31/07/2021

Sent On

17/07/2021

Sent On

09/07/2021

Sent On

08/07/2021

Sent On

08/07/2021

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.